Citigroup To $47? Plus This Analysts Predicts $95 For Papa John’s
Goldman Sachs cut Citigroup Inc. (NYSE: C) price target from $54 to $47. Citigroup shares fell 0.4% to $41.51 in pre-market trading.
Mizuho Maintains Neutral on ALLETE, Lowers Price Target to $50
Mizuho analyst Paul Fremont maintains ALLETE (NYSE:ALE) with a Neutral and lowers the price target from $58 to $50.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 361 companies set new 52-week lows.
Mizuho Maintains Neutral on ALLETE, Lowers Price Target to $58
Mizuho analyst Paul Fremont maintains ALLETE (NYSE:ALE) with a Neutral and lowers the price target from $60 to $58.
Recap: ALLETE Q2 Earnings
ALLETE (NYSE:ALE) reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
ALLETE Q2 EPS $0.67 Beats $0.63 Estimate, Sales $373.10M Beat $342.82M Estimate
ALLETE (NYSE:ALE) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.63 by 6.35 percent. This is a 26.42 percent increase over earnings of $0.53 per share from the same period
Benzinga’s Top Ratings Upgrades, Downgrades For May 25, 2022
Upgrades
Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.